ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

RDY Dr Reddys Laboratories Ltd

68.68
-1.18 (-1.69%)
May 31 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 379,195
Bid Price
Ask Price
News (1)
Day High 69.59

Low
54.48

52 Week Range

High
77.72

Day Low 68.07
Share Name Share Symbol Market Stock Type
Dr Reddys Laboratories Ltd RDY NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
-1.18 -1.69% 68.68 19:00:00
Open Price Low Price High Price Close Price Previous Close
69.50 68.07 69.59 68.68 69.86
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
5,894 379,195 US$ 68.66 US$ 26,036,747 - 54.48 - 77.72
Last Trade Type Quantity Price Currency
18:00:00 83,988 US$ 68.68 USD

Dr Reddys Laboratories Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
0 166.53M - 289.05B 55.78B - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Dr Reddys Laboratories News

Date Time Source News Article
5/31/202406:27Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/30/202410:20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/30/202410:17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/29/202405:18Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/28/202408:53Business WireDr. Reddy's Laboratories Announces the Appointment of Milan..
5/28/202406:57Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/24/202412:58Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/24/202412:16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/22/202412:23Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/21/202409:59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/21/202409:49Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/21/202409:05Business WireAlvotech and Dr. Reddy’s Enter Into Collaboration for..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No RDY Message Board. Create One! See More Posts on RDY Message Board See More Message Board Posts

Historical RDY Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week69.6071.4968.0770.21317,598-0.92-1.32%
1 Month74.8975.4368.0770.09293,953-6.21-8.29%
3 Months76.3577.2968.0771.96219,395-7.67-10.05%
6 Months69.0077.7264.5071.24230,914-0.32-0.46%
1 Year54.4877.7254.4868.65243,77414.2026.06%
3 Years72.5177.7247.8861.54203,008-3.83-5.28%
5 Years38.2377.7233.3357.81196,76430.4579.65%

Dr Reddys Laboratories Description

Headquartered in India, Dr. Reddy's Laboratories develops and manufactures generic pharmaceutical products sold across the world. The company specializes in low-cost, easy-to-produce small-molecule generic drugs and active pharmaceutical ingredients. Its drug portfolio in recent years has included biosimilar drug launches in select emerging markets and has shifted toward injectables and more complex generic products. Geographically, the company's sales are well dispersed across North America, India, and other emerging markets.